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Transition-Metal-Mediated Carbon–Fluorine Bond Formation** 
Takeru Furuya, Hanns Martin Kaiser, and Tobias Ritter* 
Fluorinated organic molecules have become increasingly important 
as pharmaceuticals
[1] and tracers for positron-emission tomography 
(PET), a powerful technology for non-invasive molecular 
imaging.
[2] The nucleus of choice for PET is fluorine-18 (
18F), which 
is typically introduced into PET tracers through the formation of 
carbon–fluorine bonds using nucleophilic fluoride (
18F¯ ) under 
harsh reaction conditions.
[3] The short half-life of 
18F of 109 minutes 
requires that carbon–fluorine bond formation occur at a late stage of 
the PET tracer synthesis, ideally as the last step. Many promising 
PET tracers for imaging are currently inaccessible due to the lack of 
suitable chemistry for the general, late-stage introduction of fluorine 
into complex, functionalized molecules.
[3, 4] Here, we present a new 
strategy for carbon–fluorine bond formation that relies on the 
fluorination of arylboronic acids via palladium complexes (eq 1). 
The reaction permits a general, regiospecific late-stage formation of 
carbon–fluorine bonds in the presence of a large variety of 
functional groups found in medicinally active molecules. Ultimately, 
we anticipate our new fluorination reaction will provide a chemical 
solution for the synthesis of currently inaccessible PET tracers to 
increase both knowledge and understanding of basic, biomedical, 
and pharmaceutical research through molecular imaging.
[5-8] 
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Carbon–fluorine bond formation is a challenging chemical 
transformation, and no general, functional-group-tolerant 
fluorination reaction of arenes is currently available for the synthesis 
of complex molecules. Simple fluoroarenes are typically synthesized 
by pyrolysis of diazonium tetrafluoroborates,
[9] direct fluorination 
using highly reactive elemental fluorine,
[10] or nucleophilic aromatic 
substitution reactions of electron-poor aromatic molecules.
[11,12] 
Common aromatic organometallics, such as aryllithiums and aryl 
Grignard reagents can afford arylfluorides when using electrophilic 
fluorine sources; however, neither aryllithiums nor aryl Grignard 
reagents can be used for the late-stage fluorination of arenes bearing 
electrophiles such as aldehydes or protic functionalities such as 
alcohols, limiting their general utility.
[13] Organometallics with 
lower basicity such as arylzinc halides, arylsilanes, arylstannanes, 
and arylboronic acids afford the formation of fluorobenzene in less 
than 10% yield (see Supporting Information). The electrophilic 
fluorination of specific carbon–hydrogen bonds of phenylpyridine 
derivatives and related structures was reported in 2006 by Sanford, 
and uses catalytic palladium (II) acetate and N-fluoropyridinium 
salts.
[14] The reaction takes advantage of a covalently attached 
pyridine directing group and affords fluorinated arylpyridine 
derivatives using microwave irradiation (100–150 °C, 1–4 h, 33–
75% yield). A different approach, the reductive elimination of 
arylfluorides from palladium (II) fluoride complexes, would obviate 
the use of directing groups and has been investigated over the past 
decade by Grushin and Yandulov.
[15,16] Carbon–fluorine bond 
formation to form aryl fluorides by reductive elimination from a Pd 
(II) fluoride complex has not yet been substantiated.
[16,17] In general, 
all methods mentioned above cannot be employed for late-stage 
fluorination of structurally complex molecules due to either harsh 
reaction conditions or limited substrate scope. 
We have sought a new regiospecific, late-stage fluorination 
reaction of arenes that encompasses a larger substrate scope than 
currently accessible, tolerates the presence of a variety of functional 
groups, is not limited to a particular class of arenes, and is not 
dependent on a directing group. Our strategy is illustrated in 
equation 1, and consists of the synthesis of new aryl palladium 
complexes that react with the electrophilic fluorination reagent 
Selectfluor
™[18] to afford fluoroarenes. Our initial investigations for 
the design of transition-metal complexes that afford efficient 
fluorination was guided by the observation that palladium has been 
successfully employed in several carbon-heteroatom bond 
formations,
[19,20] including carbon–fluorine bonds for specific 
substrates.
[14, 21] Additionally, the development of our methodology 
was directed by the necessity to predict and control the exact 
location of fluorination and the need to introduce fluorine at any 
desired aromatic position. Therefore, the target molecules for 
fluorination are pre-functionalized with boronic acids at the position 
where fluorine is desired. Boronic acids are readily accessible, 
compatible with a variety of functional groups present in PET 
tracers, competent nucleophiles for transmetallation to palladium, 
and can be introduced into complex molecules.
[22] 
Several aryl palladium complexes based on ligands that are 
commonly used for palladium chemistry did not yield carbon–
fluorine bond formation when evaluated for fluorination. We 
therefore designed new aryl palladium complexes that are derived 
from a bidentate nitrogenous ligand that contains a neutral and an 
anionic nitrogen donor atom for coordination to palladium. Our 
design was based on the assumptions that nitrogenous ligands resist 
oxidation by electrophilic fluorination reagents, can support high-
valent aryl palladium fluorides for subsequent carbon–fluorine 
reductive elimination, and do not induce competing nitrogen–
fluorine reductive elimination. We prepared the new palladium 
acetate complex 1 by known sulfonamide insertion
[23] into the 
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palladium–carbon bond of benzoquinoline-derived palladacycle 
3,
[24] followed by chloride-acetate ligand exchange (eq 2). The aryl 
palladium complexes 4a–m were prepared by transmetallation using 
12 different arylboronic acids (Table 1). Transmetallation proceeded 
at 23 °C in a basic methanol/benzene solution and afforded the 
palladium complexes as moisture and air stable yellow solids in 65–
91% yield on a 400 mg scale after purification by chromatography 
on silica gel. The aryl palladium complexes derived from 1 are 
tolerant toward the presence of a variety of functional groups found 
in medicinally active compounds, including alcohols, an indole, and 
a primary amide. The phenyl palladium sulfonamide 4a (R = H) 
crystallized in a square planar geometry with the aryl group trans to 
the κ
1-sulfonamide ligand (Figure 1). The trans relationship may be 
crucial to prevent undesired carbon–nitrogen bond formation 
through reductive elimination of the aryl and sulfonamide 
substituents.
[25] 
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Figure 1. ORTEP diagrams of 1 and 4a with thermal ellipsoids at 
50% probability showing the trans relationship of the sulfonamide 
nitrogen atom to the acetate and aryl ligand, respectively. 
Fluorination of the aryl palladium complexes 4a–m using the 
electrophilic reagent Selectfluor
™ (2) afforded the arylfluorides 5a–
m regiospecifically in 31–82% isolated yield (Table 2). Our 
fluorination reaction tolerates the presence of a variety of 
functional-groups, most notably protic functionalities that are not 
typically compatible with nucleophilic aromatic substitution 
methods due to the high basicity of fluoride ion in anhydrous 
solvents suitable for nucleophilic displacement.
10  Additionally, 
electron-rich fluoroarenes (5b, 5g, 5h), which cannot be synthesized 
through late-stage fluorination using nucleophilic displacement, are 
accessible regiospecifically. The scope of the reaction was further 
extended to electron-poor (5e,  5l), hetero (5m), and ortho-
substituted arenes (5k). Fluorination proceeds in 30 minutes when 
performed in acetonitrile or acetone at 50 °C. While fluorination  
Table 1. Transmetallation to form arylpalladium (II) complexes. 
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Table 2. Electrophilic fluorination of arylpalladium complexes. 
MeCN, 50 °C, 30 min
N
N-p-Ns
Pd py
N
N
F
Cl
2BF4 F
R
4a−m
2
R
5a−m
[PdII] +
6
     (4)
4  product yield  4  product yield 
4a 
F
 
5a
a 
81%  4g 
F
HO  
5g
b 
31% 
4b  tBu
F
 
5b
a 
79%  4h 
F
MeO  
5h
b 
46% 
4c 
F
Ph  
5c 
72%  4i 
F
Br  
5i 
73% 
4d 
F
HO  
5d 
70%  4k 
F
Me
Cl
 
5k 
82% 
4e 
F
H
O  
5e 
61%  4l 
F
F3C  
5l
a 
54% 
4f 
F
H2N
O  
5f 
74%  4m  N
Boc
F
 
5m
b 
60% 
[a] Yield for this entry determined by 
19F NMR analysis due to low 
boiling point of product.  [b] Acetone used as solvent.   3
was observed at 23 °C, the highest yields were obtained at a reaction 
temperature of 50 °C. Yields of isolated products were identical 
when the fluorination reactions were performed under rigorous 
exclusion of air and moisture or open to the atmosphere. 
The fate of the palladium after fluorination was determined to be 
cationic palladium complex 6, which was independently synthesized 
by treatment of palladium chloride 7 with silver tetrafluoroborate in 
acetonitrile (Scheme 1). Subsequent reaction of 6 with one 
equivalent of pyridine afforded the stable palladium 
tetrafluoroborate salt 8, which was isolated and characterized. 
Addition of pyridine after termination of the reaction displayed in 
equation 4, table 2 also afforded 8, which suggests that the pyridine-
sulfonamide ligand remained coordinated to palladium throughout 
the reaction. The stability of the ligand-metal complex is 
advantageous for a prospective catalytic version of the presented 
fluorination reaction. 
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Scheme 1. Independent synthesis of palladium byproduct 6. 
Transition-metal catalysis for carbon–fluorine bond formations 
is a valuable goal in itself. However, for the synthesis of PET tracers, 
a fluorination reaction using stoichiometric amounts of transition-
metal is superior to a catalytic version. Reactions stoichiometric in 
transition-metal are faster than the corresponding catalyzed 
reactions, and time is the most important factor for the efficient 
preparation of PET tracers due to the short half-life of 
18F. Moreover, 
price and toxicity of palladium are of lesser importance for 
applications in molecular imaging because PET tracers are used in 
picomolar quantities and are purified by HPLC before injection in 
vivo. 
Two possible mechanisms for the presented fluorination reaction 
are electrophilic palladium–carbon bond cleavage and carbon–
fluorine reductive elimination from a discrete, high-valent palladium 
fluoride.
21 The redox activity of palladium (II) may play a crucial 
role for fluorination, which suggests a high-valent, discrete 
palladium fluoride complex as an intermediate before carbon–
fluorine reductive elimination. Neither of the two mechanisms can 
be ruled out based on our experimental observations. 
In conclusion, we report a fluorination reaction of arylboronic 
acids mediated by palladium, in which carbon–fluorine bond 
formation is the final synthetic step. The functional group tolerance, 
broad substrate scope, and regiospecificity of the reaction provide a 
general method for the late-stage fluorination of functionalized 
arenes. This new chemistry could be the basis for the development 
of a general solution for the synthesis of PET tracers for biomedical 
applications. Electrophilic 
18F sources are available, but from a 
biomedical perspective nucleophilic 
18F¯ is the preferred source of 
fluorine for PET imaging because it can be prepared in high specific 
activity.
3 A subsequent goal is therefore the development of an 
electrophilic fluorine source originating from nucleophilic fluoride 
(
18F¯). Further development of the transformation presented herein, 
in combination with known or new electrophilic fluorine sources, 
may deliver promising PET tracers to impact biomedical research in 
the fields of cancer, neurodegenerative diseases, gene therapy, and 
drug development. 
Experimental Section 
A representative transmetallation/fluorination sequence is described 
below:  
 
Aryl palladium complex 4c: To acetato palladium complex 1 (400 mg, 
0.642 mmol, 1.00 equiv) in MeOH (12 mL) and benzene (12 mL) at 23 
ºC is added 4-biphenyl boronic acid (140 mg, 0.706 mmol, 1.10 equiv) 
and K2CO3 (133 mg, 0.963 mmol, 1.50 equiv). The reaction mixture 
is stirred at 23 ºC for 11 h, and the solvent is removed in vacuo. To 
the solid residue is added CHCl3  (5 mL) and water (5 mL). The 
phases are separated and the aqueous phase is extracted with 
CHCl3 (3 × 5 mL). The combined organic phases are washed with 
brine (5 mL) and dried (Na2SO4). The filtrate is concentrated in vacuo 
and the residue is purified by chromatography on silica gel eluting 
with hexane/EtOAc 1:1 (v/v) to afford 418 mg of the title compound as 
a yellow solid (91% yield).  
 
4-Fluorobiphenyl  5c: To 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo-
[2.2.2]octane bis(tetrafluoroborate) (2) (85.0 mg, 0.240 mmol, 1.20 
equiv) in acetonitrile (6.0 mL) at 50 ºC is added aryl palladium 
complex  4c  as a solid (143 mg, 0.200 mmol, 1.00 equiv) in 10 
portions over 10 min. The reaction mixture is subsequently stirred at 
50 ºC for 20 min. After cooling to 23 ºC, pyridine is added to the 
reaction mixture (8.1 µL, 0.10 mmol, 1.0 equiv), and the reaction 
mixture is filtered through a plug of celite. The filtrate is concentrated 
in vacuo and the residue is purified by chromatography on silica gel 
eluting with hexane/EtOAc 99:1 (v/v) to afford 24.8 mg of the title 
compound as a white solid (72% yield). 
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Materials and Methods 
All reactions were carried out under an ambient atmosphere unless otherwise mentioned. Except as indicated 
otherwise, reactions were magnetically stirred and monitored by thin layer chromatography (TLC) using 
EMD TLC plates pre-coated with 250 μm thickness silica gel 60 F254 plates and visualized by fluorescence 
quenching under UV light. In addition, TLC plates were stained using ceric ammonium molybdate or 
potassium permanganate stain. Flash chromatography was performed on Dynamic Adsorbents Silica Gel 40–
63 μm particle size using a forced flow of eluant at 0.3–0.5 bar pressure.
1 Concentration under reduced 
pressure was performed by rotary evaporation at 25–30 ºC at appropriate pressure. Purified compounds were 
further dried under high vacuum (0.01–0.05 Torr). Yields refer to purified and spectroscopically pure 
compounds. Melting points were measured on a Büchi 510 apparatus. All melting points were measured in 
open capillaries and are uncorrected. NMR spectra were recorded on a Varian Unity/Inova 500 spectrometer 
operating at 500MHz and 125MHz for 
1H and 
13C acquisitions, respectively, or on a Varian Mercury 400 
spectrometer operating at 375 MHz for 
19F acquisition. Chemical shifts (δ) of 
1H-NMR and 
13C-NMR spectra 
are reported in ppm with the solvent resonance as the internal standard. Chemical shifts (δ) of 
19F-NMR 
measurements are reported relatively to CFCl3 as the external standard. Data is reported as follows: s = singlet, 
br = broad, d = doublet, t = triplet, q = quartet, m = multiplet; coupling constants in Hz; integration. High-
resolution mass spectra were obtained on Jeol AX-505 or SX-102 spectrometers at the Harvard University 
Mass Spectrometry Facilities. THF was distilled from sodium/ benzophenone prior to use. Benzo[h]quinoline 
was purchased from TCI America. Iodobenzene diacetate, 4-nitrobenzenesulfonyl amide, phenyllithium (1.6 
M in dibutylether), phenylmagnesium bromide (1.0 M in THF), 4-chlorophenylmagnesium bromide (1.0 M in 
Et2O), tributylphenyltin, and N-fluorobenzene-sulfonimide were purchased from Aldrich. Palladium acetate 
and boronic acids were purchased from Frontier Scientific or Boron Molecular. Phenyltrimethylsilane and 1-
chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) were purchased from VWR 
and used as received. Phenylzinc chloride
2 and potassium phenyltrifluoroborate
3 were synthesized according 
to the literature procedures. 
                                                      
 
1 Still, W. C., Kahn, M. & Mitra, A. Rapid chromatographic technique for preparative separations with 
moderate resolution. J. Org. Chem. 43, 2923-2925 (1978). 
2 Jansen, A. & Krause, N. Transition metal-promoted synthesis of functionalized and unfunctionalized 
pyridylallenes. Synthesis 14, 1987-1993 (2002). 
3 Vedejs, E., Chapman, R. W., Fields, S.C., Lin, S & Schrimpf, M. R. Conversion of arylboronic acids into 
potassium aryltrifluoroborates: convenient precursors of arylboron difluoride lewis acids. J. Org. Chem. 60, 
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Experimental Data 
Experimental Procedures and Compound Characterization 
General procedure A for the fluorination of aryllithium, arylmagnesium, and arylzinc substrates: 
M
N
N
F
Cl
or
(PhSO2)2NF
THF
F
R = H, Cl; M = Li, MgBr, ZnCl
R R
2 BF4
-
 
Under nitrogen atmosphere, the main-group organometallic (0.0400 mmol, 1.00 equiv) is added to 1-
chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoro-borate) (14.2 mg, 0.0400 mmol, 1.00 
equiv) or N-fluorobenzenesulfoneimide (12.6 mg, 0.0400 mmol, 1.00 equiv) in THF (0.4 mL) at 23 ºC. The 
reaction mixture is stirred at 23 ºC for 12 hr and to the reaction mixture is added 3-nitrofluorobenzene (4.00 
μL, 0.0376 mmol). The yields are determined by comparing integration of the 
19F-NMR (375 MHz, CDCl3, 
23 ºC) resonance of fluorobenzene (–115.3 ppm) or 1-chloro-4-fluorobenzene (–116.5 ppm) and that of 3-
nitrofluorobenzene (–112.0 ppm). Yields are reported in Table S1. 
General procedure B for the fluorination of arysilane, arylstannate, and arylboronic acid derivatives: 
M
N
N
F
Cl
MeCN, 50 °C
F
M = SiMe3, SnBu3, B(OH)2, BF3K
2 BF4
-
 
To 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (14.2 mg, 0.0400 mmol, 
1.00 equiv) in acetonitrile (0.4 mL) at 23 ºC is added the main-group organometallic (0.0400 mmol, 1.00 
equiv). The reaction mixture is stirred at 50 ºC for 12 hr and to the reaction mixture is added 3-
nitrofluorobenzene (4.00 μL, 0.0376 mmol). The yields are determined by comparing integration of the 
19F-
NMR (375 MHz, CDCl3, 23 ºC) resonance of fluorobenzene (–115.3 ppm) and that of 3-nitrofluorobenzene (–
112.0 ppm). Yields are reported in Table S1. 
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Table S1.: Direct synthesis of fluorobenzene derivatives employing electrophilic fluorine sources: 
Organometallic Reagent  Product  Yield  [%] 
(19F-NMR) 
PhLi (PhSO2)2NF PhF
a 39 
PhMgBr (PhSO2)2NF PhF
a 50 
4-Cl-C6H4MgBr (PhSO2)2NF 4-Cl-C6H4F
a 38 
PhZnCl Selectfluor  PhF
a 6 
PhB(OH)2 Selectfluor  PhF
b 4 
PhSiMe3 Selectfluor  –
b 0 
PhSnBu3 Selectfluor  –
b 0 
a following general procedure A 
b following general procedure B  
 [{(4-Nitrophenyl)sulfonyl}imino]phenyliodinane
4,
5 
I
OAc
OAc
KOH
p-NsNH2
MeOH
I
N
S
O
O
NO2
84 %  
To 4-nitrobenzenesulfonyl amide (5.00 g, 24.8 mmol, 1.00 equiv) in methanol (100 mL) at 23 ºC is added 
potassium hydroxide (3.48 g, 62.0 mmol, 2.50 equiv). The reaction mixture is stirred at 23 ºC for 10 min and 
cooled to 0 ºC. To the reaction mixture at 0 ºC is added iodobenzene diacetate (7.98 g, 24.8 mmol, 1.00 equiv). 
The reaction mixture is stirred at 0 ºC for 10 min and further stirred at 23 ºC for 2.0 h. The reaction mixture is 
poured onto cold water (700 mL) and kept at 0 ºC for 4 h. The suspension is filtered off and the filter cake is 
washed with water (2 × 200 mL) and methanol (2 × 200 mL) to afford 8.39 g of the title compound as a white 
solid (84% yield). 
1H-NMR (500 MHz, DMSO-d-6, 23 ºC): δ 8.02 (d, J = 9.0 Hz, 2H), 7.73 (d, J = 9.0 Hz, 2H), 7.71 (d, J = 6.5 
Hz, 2H), 7.41 (t, J = 7.0 Hz, 1H), 7.26 (dd, J = 8.0 Hz, J = 7.5 Hz, 2H); 
13C-NMR (125 MHz, DMSO-d-6, 23 
ºC): δ 151.7, 148.6, 134.4, 131.4, 130.9, 128.2, 124.3, 117.9. These spectroscopic data correspond to the 
                                                      
 
4 Yamada, Y.; Yamamoto, T. & Okawara, M. Synthesis and reaction of new type I-N ylide, N-
tosyliminoiodinane. Chem. Lett. 4, 361–362 (1975). 
5 Gullick, J.; Ryan, D.; McMorn, P.; Bethell, D.; King, F.; Hancock, F.; Hutching, G. Catalytic asymmetric 
heterogeneous aziridination of styrene using Cu
2+-exchanged zeolite Y: effect of the counter-cation on 
enantioselectivity and on the reaction profile. New J. Chem. 28, 1470–1478 (2004). Supporting Information    S7 
 
reported data in reference 5.  
Benzo[h]quinolinyl palladium acetate dimer
6 
N
Pd(OAc)2
MeOH
86 %
N
Pd
Ac
O
2
 
To benzo[h]quinoline (2.60 g, 14.5 mmol, 1.00 equiv) in MeOH (230 mL) at 23 ºC is added palladium acetate 
(3.26 g, 14.5 mmol, 1.00 equiv). After stirring for 3.0 h, the suspension is filtered off and the filter cake is 
washed with MeOH (100 mL) and Et2O (100 mL) to afford 4.27 g of the title compound as a yellow solid 
(86% yield). 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 7.80 (dd, J = 5.5 Hz, 1.5 Hz, 1H), 7.43 (dd, J = 8.0 Hz, J = 1.5 Hz, 1H), 
7.24–7.18 (m, 3H), 7.08 (dd, J = 7.0 Hz, J = 1.5 Hz, 1H), 6.97 (d, J = 9.0 Hz, 1H), 6.46 (dd, J = 7.5 Hz, 5.0 
Hz, 1H), 2.38 (s, 3H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 182.5, 153.2, 148.9, 148.8, 140.0, 135.3, 132.4, 
129.0, 127.9, 127.7, 125.0, 122.9, 122.1, 119.8, 25.2. These spectroscopic data correspond to the reported data 
in reference 6. 
Benzo[h]quinolinyl palladium chloro dimer
7 
LiCl
EtOH
98 %
N
Pd
Cl
2 N
Pd
Ac
O
2
 
To benzo[h]quinolinyl palladium acetate dimer (4.27 g, 12.4 mmol, 1.00 equiv) in EtOH (100mL) at 0 ºC is 
added lithium chloride (10.5 g, 24.8 mmol, 20.0 equiv). The reaction mixture is warmed to 23 ºC and stirred 
for 1.0 h. The reaction mixture is filtered off and the filter cake is washed with water (3 × 100 mL), MeOH (2 
× 100 mL), and Et2O (100 mL) to afford 3.89 g of the title compound as a pale yellow solid (98% yield). 
1H-NMR (500 MHz, DMSO-d-6, 23 ºC): δ 9.44 (d, J = 4.5 Hz, 1.0 Hz, 1H), 8.72 (br), 8.67 (d, J = 7.5 Hz, 
1H), 8.61 (br), 8.22 (d, J = 7.0 Hz, 1H), 7.91 (d, J = 9.0 Hz, 1H), 7.86–7.74 (m, 3H), 7.73 (br), 7.60 (br), 7.53 
                                                      
 
6 Dick, A. R., Hull , K. L. & Sanford, M. S. A Highly selective catalytic method for the oxidative 
functionalization of C-H bonds. J. Am. Chem. Soc. 126, 2300–2301(2004). 
7 Hartwell, G. E., Lawrence, R. W. & Smas, M. J. The formation of palladium(II)– and platinum(II)–carbon 
bonds by proton abstraction from benzo[h]quinoline and 8-methylquinoline. J. Chem. Soc. D.: Chem. 
Commun. 912 (1970).
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(dd, J = 7.5 Hz, J = 7.0 Hz 1H), 7.38 (br); 
13C-NMR (125 MHz, DMSO-d-6, 23 ºC): δ 153.9, 152.2, 150.7, 
150.6, 148.0, 141.7, 139.9, 134.4, 130.8, 129.6, 129.4, .127.5, 125.1, 124.4, 123.0, 122.9. Note: The 
complicated 
1H and 
13C-NMR spectra are probably due to the mixture of the title compound and solvent 
adduct in DMSO-d-6. The title compound is not soluble in non-coordinating solvents. 
Chloro palladium complex 7
8 
pyridine, 
PhI=N-p-Ns
THF
78 %
N
Pd
Cl
2
NP d
N
N
Cl
S
NO2 O O
37  
To chloropalladium dimer 3 (1.60 g, 5.00 mmol, 1.00 equiv) in THF (75.0 mL) at 23 ºC is added pyridine 
(3.20 mL, 40.0 mmol, 8.00 equiv) and PhI=N-p-Ns (3.00 g, 7.50 mmol, 1.50 equiv). The reaction mixture is 
stirred at 23 ºC for 17 h. The reaction mixture is filtered off and the filter cake is washed with Et2O (2 × 10 
mL) to afford 2.40 g of the title compound as a light brown solid (78% yield). 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 9.20 (dd, J = 4.5 Hz, 1.0 Hz, 1H), 8.97 (d, J = 4.5 Hz, 2H), 8.07 (dd, J 
= 6.5 Hz, 1.0 Hz, 1H), 7.92–7.82 (m, 5H), 7.53–7.45 (m, 5H), 7.39 (dd, J = 6.5 Hz, 4.5 Hz, 1H), 7.32 (d, J = 
6.0 Hz, 2H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 154.1, 152.5, 148.3, 147.3, 141.6, 138.9, 137.8, 137.7, 
136.1, 130.7, 130.1, 128.3, 127.1, 126.9, 126.8, 126.2, 125.3, 124.5, 122.5, 122.3. These spectroscopic data 
correspond to the reported data in reference 6.  
Acetato palladium complex 1 
AgOAc
CH2Cl2
89 % NP d
N
N
OAc
S
NO2 O O
1
NP d
N
N
Cl
S
NO2 O O
7  
To chloro palladium complex 7 (2.22 g, 3.70 mmol, 1.00 equiv) in CH2Cl2 (74.0 mL) at 23 ºC is added 
AgOAc (3.09 g, 18.5 mmol, 5.00 equiv). The suspension is stirred at 40 ºC for 2.0 h. After cooling to 23 ºC, 
the suspension is filtered through a plug of celite. The filtrate is concentrated in vacuo and the residue is 
                                                      
 
6 Dick, A. R., Remy, M. S., Kampf, J. W. & Sanford, M. S. Carbon-nitrogen bond-forming reactions of 
palladacycles with hypervalent iodine reagents. Organometallics 26, 1365–1370 (2007). Supporting Information    S9 
 
triturated with Et2O (50 mL). The solids are filtered off and washed with Et2O (2 × 50 mL) to afford 2.04 g of 
the title compound as an orange yellow solid (89% yield).  
m.p.: 211 °C (decomp.); 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 8.93 (d, J = 4.5 Hz, 2H), 8.71 (dd, J = 4.5 Hz, 
1.5 Hz, 1H), 8.06 (d, J = 6.5 Hz, 1H), 7.90–7.76 (m, 5H), 7.52 (d, J = 7.0 Hz, 2H) 7.48–7.41 (m, 5H), 7.34 
(dd, J = 6.5 Hz, 4.5 Hz, 1H), 1.79 (s, 3H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 177.8, 152.0, 151.4, 148.4, 
147.9, 141.8, 139.0, 138.8, 138.1, 136.2, 130.8, 130.5, 129.1, 127.5, 127.0, 126.8, 126.3, 125.3, 124.5, 122.6, 
122.2, 24.0; HRMS-FIA (m/z): [M – OAc + MeCN]
+ calcd for C26H20N4O6PdS, 604.0265; found, 604.0308.  
Anal: calcd for C26H20N4O6PdS: C, 50.13; H, 3.24; N, 9.00; found: C, 49.93; H, 3.44; N, 8.79.  Crystal 
structure is shown in the X-ray Crystallographic Analysis section. 
Aryl palladium complex 4a 
PhB(OH)2, 
K2CO3
MeOH:benzene 
(1:1)
76 %
NP d
N
N
S
NO2 O O
4a
NP d
N
N
OAc
S
NO2 O O
1  
To acetato palladium complex 1 (400 mg, 0.642 mmol, 1.00 equiv) in MeOH (12.8 mL) and benzene (12.8 
mL) at 23 ºC is added phenylboronic acid (86.0 mg, 0.706 mmol, 1.10 equiv) and K2CO3 (133 mg, 0.963 
mmol, 1.50 equiv). The reaction mixture is stirred at 23 ºC for 2.5 h, and the solvent is removed in vacuo. To 
the solid residue is added CHCl3 (5 mL) and water (5 mL). The phases are separated and the aqueous phase is 
extracted with CHCl3 (3 × 5 mL). The combined organic phases are washed with brine (5 mL) and dried 
(Na2SO4). The filtrate is concentrated in vacuo and the residue is purified by chromatography on silica gel 
eluting with hexane/EtOAc 1:1 (v/v) to afford 314 mg of the title compound as a pale yellow solid (76% 
yield). 
TLC (hexane/EtOAc 1:1, v/v): RF = 0.23; m.p.: 205 °C (decomp.); 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 9.00 
(d, J = 6.5 Hz, 2H), 8.27 (dd, J = 5.5 Hz, 1.5 Hz, 1H), 7.93 (dd, J = 8.0 Hz, 1.5Hz, 1H), 7.79–7.69 (m, 5H), 
7.48 (d, J = 9.0 Hz, 2H), 7.38 (d, J = 9.0 Hz, 2H), 7.35–7.28 (m, 4H), 7.03 (dd, J = 8.0 Hz, 6.5 Hz, 1H), 6.84–
6.76 (m, 4H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 155.3, 153.9, 153.3, 149.4, 147.8, 144.6, 144.3, 138.0, 
137.9, 136.5, 134.8, 130.5, 130.2, 128.5, 127.6, 127.2, 127.0, 126.8, 125.2, 124.7, 124.4, 123.8, 122.4, 121.5; 
HRMS-FIA (m/z): [M + H]
+ calcd for C30H22N4O4PdS, 641.0475; found, 641.0475. Anal: calcd for 
C30H22N4O4PdS: C, 56.21; H, 3.46; N, 8.74; found: C, 55.94; H, 3.48; N, 8.40.  Crystal structure is shown in 
the X-ray Crystallographic Analysis section. Supporting Information    S10 
 
Aryl palladium complex 4b 
K2CO3
MeOH:benzene 
(1:1)
85 %
NP d
N
N
S
NO2 O O
4b
NP d
N
N
OAc
S
NO2 O O
1
tBu (HO)2B
tBu
 
To acetato palladium complex 1 (400 mg, 0.642 mmol, 1.00 equiv) in MeOH (12.8 mL) and benzene (12.8 
mL) at 23 ºC is added 4-tert-butylphenylboronic acid (126 mg, 0.706 mmol, 1.10 equiv) and K2CO3 (133 mg, 
0.963 mmol, 1.50 equiv). The reaction mixture is stirred at 23 ºC for 13 h, and the solvent is removed in 
vacuo. To the solid residue is added CHCl3 (5 mL) and water (5 mL). The phases are separated and the 
aqueous phase is extracted with CHCl3 (3 × 5 mL). The combined organic phases are washed with brine (5 
mL) and dried (Na2SO4). The filtrate is concentrated in vacuo and the residue is purified by chromatography 
on silica gel eluting with hexane/EtOAc 3:2 (v/v) to afford 381 mg of the title compound as a yellow solid 
(85% yield). 
TLC (hexane/EtOAc 1:1, v/v): RF = 0.49; m.p.: 171 ºC (decomp.); 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 9.00 
(d, J = 5.0 Hz, 2H), 8.27 (dd, J = 5.5 Hz 1.5 Hz, 1H), 7.92 (dd, J = 8.0 Hz, 1.5 Hz, 1H), 7.80–7.70 (m, 5H), 
7.48 (d, J = 9.0 Hz, 2H), 7.38 (d, J = 8.5 Hz, 1H), 7.36–7.30 (m, 4H), 7.03 (dd, J = 8.0 Hz, 5.0 Hz, 1H), 6.81 
(d, J = 9.0 Hz, 2H), 6.70 (d, J = 8.5 Hz, 2H), 1.19 (s, 9H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 154.0, 
153.4, 150.5, 149.5, 147.8, 146.4, 144.6, 142.3, 137.9, 137.8, 136.4, 134.0, 130.4, 130.1, 128.5, 127.4, 126.9, 
126.8, 125.1, 124.6, 124.4, 124.2, 122.4, 121.4, 34.1, 31.7; HRMS-FIA (m/z): [M + H]
+ calcd for 
C34H30N4O4PdS, 697.1095; found, 697.1082. Anal: calcd for C34H30N4O4PdS: C, 58.58; H, 4.34; N, 8.04; 
found: C, 58.27; H, 4.37; N, 7.84. 
Aryl palladium complex 4c 
K2CO3
MeOH:benzene 
(1:1)
91 %
NP d
N
N
S
NO2 O O
4c
NP d
N
N
OAc
S
NO2 O O
1
Ph (HO)2B
Ph
 
To acetato palladium complex 1 (400 mg, 0.642 mmol, 1.00 equiv) in MeOH (12.8 mL) and benzene (12.8 
mL) at 23 ºC is added 4-biphenyl boronic acid (140 mg, 0.706 mmol, 1.10 equiv) and K2CO3 (133 mg, 0.963 Supporting Information    S11 
 
mmol, 1.50 equiv). The reaction mixture is stirred at 23 ºC for 11 h, and the solvent is removed in vacuo. To 
the solid residue is added CHCl3 (5 mL) and water (5 mL). The phases are separated and the aqueous phase is 
extracted with CHCl3 (3 × 5 mL). The combined organic phases are washed with brine (5 mL) and dried 
(Na2SO4). The filtrate is concentrated in vacuo and the residue is purified by chromatography on silica gel 
eluting with hexane/EtOAc 1:1 (v/v) to afford 418 mg of the title compound as a yellow solid (91% yield). 
TLC (hexane/EtOAc 3:7, v/v): RF = 0.79; m.p.: 180 ºC (decomp.); 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 9.04 
(d, J = 6.5 Hz, 2H), 8.32 (dd, J = 5.0 Hz, 2.0 Hz, 1H), 7.95 (dd, J = 8.0 Hz, 1.5 Hz, 1H), 7.81–7.71 (m, 5H), 
7.50–7.45 (m, 4H), 7.40 (d, J = 9.0 Hz, 1H), 7.38–7.29 (m, 6H), 7.24 (t, J = 7.5 Hz, 1H), 7.09–7.05 (m, 3H), 
6.88 (d, J = 8.0 Hz, 2H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 154.6, 154.1, 153.4, 149.3, 147.8, 144.6, 
142.2, 141.4, 138.1, 138.0, 136.5, 135.1, 130.5, 130.2, 128.9, 128.6, 127.6, 127.1, 127.0, 126.9, 126.8, 126.7, 
125.6, 125.2, 124.7, 124.4, 122.4, 121.6; HRMS-FIA (m/z): [M + H]
+ calcd for C36H26N4O4PdS, 717.0782; 
found, 717.0786. Anal: calcd for C36H26N4O4PdS: C, 60.30; H, 3.65; N, 7.82; found: C, 60.27; H, 3.65; N, 
7.60. 
 
Aryl palladium complex 4d 
K2CO3
MeOH:benzene 
(1:1)
80 %
NP d
N
N
S
NO2 O O
4d
NP d
N
N
OAc
S
NO2 O O
1
(HO)2B
OH
HO
 
To acetato palladium complex 1 (400 mg, 0.642 mmol, 1.00 equiv) in MeOH (12.8 mL) and benzene (12.8 
mL) at 23 ºC is added 4-(hydroxymethyl)phenylboronic acid (133 mg, 0.706 mmol, 1.10 equiv) and K2CO3 
(133 mg, 0.963 mmol, 1.50 equiv). The reaction mixture is stirred at 23 ºC for 11 h, and the solvent is 
removed in vacuo. To the solid residue is added CHCl3 (5 mL) and water (5 mL). The phases are separated 
and the aqueous phase is extracted with CHCl3 (3 × 5 mL). The combined organic phases are washed with 
brine (5 mL) and dried (Na2SO4). The filtrate is concentrated in vacuo and the residue is purified by 
chromatography on silica gel eluting with hexane/EtOAc 1:4 (v/v) to afford 344 mg of the title compound as a 
yellow solid (80% yield). 
TLC (hexane/EtOAc 3:7, v/v): RF = 0.37; m.p.: 158 ºC (decomp.); 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 8.99 
(d, J = 6.5 Hz, 2H), 8.25 (dd, J = 5.5 Hz, 1.5 Hz, 1H), 7.94 (dd, J = 8.5Hz, 2.0 Hz, 1H), 7.80–7.69 (m, 5H), 
7.47 (d, J = 9.0 Hz, 2H), 7,39 (d, J = 9.0 Hz, 1H), 7.36–7.27 (m, 4H), 7.04 (dd, J = 8.5 Hz, 6.5 Hz, 1H), 6.81 
(m, 4H), 4.50 (d, J = 4.0 Hz, 2H), 1.49 (t, J = 4.0 Hz, 1H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 154.6, 
153.9, 153.3, 149.3, 147.8, 144.5, 142.2, 138.0, 137.9, 136.5, 136.2, 134.8, 130.5, 130.2, 128.5, 127.5, 126.9, 
126.8, 126.2, 125.2, 124.7, 124.4, 121.5, 122.4, 65.5; HRMS-FIA (m/z): [M + H]
+ calcd for C31H24N4O5PdS, Supporting Information    S12 
 
671.0575; found, 617.0598. Anal: calcd for C31H24N4O5PdS: C, 55.49; H, 3.61; N, 8.35; found: C, 55.10; H, 
3.51; N, 7.99. 
 
Aryl palladium complex 4e 
K2CO3
MeOH:benzene 
(1:1)
71 %
NP d
N
N
S
NO2 O O
4e
NP d
N
N
OAc
S
NO2 O O
1
(HO)2B
O
O
 
To acetato palladium complex 1 (400 mg, 0.642 mmol, 1.00 equiv) in MeOH (12.8 mL) and benzene (12.8 
mL) at 23 ºC is added 4-formylphenylboronic acid (133 mg, 0.706 mmol, 1.10 equiv) and K2CO3 (133 mg, 
0.963 mmol, 1.50 equiv). The reaction mixture is stirred at 23 ºC for 18 h, and the solvent is removed in 
vacuo. To the solid residue is added CHCl3 (5 mL) and water (5 mL). The phases are separated and the 
aqueous phase is extracted with CHCl3 (3 × 5 mL). The combined organic phases are washed with brine (5 
mL) and dried (Na2SO4). The filtrate is concentrated in vacuo and the residue is purified by chromatography 
on silica gel eluting with hexane/EtOAc 1:1 (v/v) to afford 304 mg of the title compound as a yellow solid 
(71% yield). 
TLC (hexane/EtOAc 3:7, v/v): RF = 0.40; m.p.: 166 ºC (decomp.); 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 9.77 
(s, 1H), 8.97 (d, J = 6.0 Hz, 2H), 8.17 (dd, J = 6.5 Hz, 1.5 Hz, 1H), 7.98 (dd, J = 7.5 Hz, 1.5Hz, 1H), 7.84–
7.79 (m, 2H), 7.76–7.71 (m, 3H), 7.48 (d, J = 8.0 Hz, 2H), 7.44–7.36 (m, 3H), 7.31–7.25 (m, 4H), 7.12 (d, J = 
7.5 Hz, 2H), 7.07 (dd, J = 8.0 Hz, 5.5 Hz, 1H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 192.9, 169.1, 153.7, 
153.2, 149.0, 147.9, 144.4, 141.9, 138.4, 138.3, 136.5, 135.5, 133.2, 130.7, 130.4, 128.5, 127.7, 127.6, 126.9, 
126.8, 125.4, 124.8, 124.4, 122.4, 121.7; HRMS-FIA (m/z): [M + H]
+ calcd for C31H22N4O5PdS, 669.0419; 
found, 669.0426. Anal: calcd for C31H22N4O5PdS: C, 55.65; H, 3.31; N, 8.38; found: C, 55.43; H, 3.58; N, 
8.09. 
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Aryl palladium complex 4f 
K2CO3
MeOH:benzene 
(1:1)
73 %
NP d
N
N
S
NO2 O O
4f
NP d
N
N
OAc
S
NO2 O O
1
(HO)2B
O
O
NH2
H2N
 
To acetato palladium complex 1 (400 mg, 0.642 mmol, 1.00 equiv) in MeOH (12.8 mL) and benzene (12.8 
mL) at 23 ºC is added 4-aminocarbonylphenylboronic acid (116 mg, 0.706 mmol, 1.10 equiv) and K2CO3 
(133 mg, 0.963 mmol, 1.50 equiv). The reaction mixture is stirred at 23 ºC for 11 h, and the solvent is 
removed in vacuo. To the solid residue is added CHCl3 (5 mL) and water (5 mL). The phases are separated 
and the aqueous phase is extracted with CHCl3 (3 × 5 mL). The combined organic phases are washed with 
brine (5 mL) and dried (Na2SO4). The filtrate is concentrated in vacuo and the residue is purified by 
chromatography on silica gel eluting with EtOAc to afford 319 mg of the title compound as a yellow solid 
(73% yield). 
TLC (EtOAc): RF = 0.21; m.p.: 175 ºC (decomp.); 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 8.97 (d, J = 5.5 Hz, 
2H), 8.19 (dd, J = 6.5 Hz, 1.5 Hz, 1H), 7.97 (dd, J = 7.5 Hz, 1.5Hz, 1H), 7.83–7.70 (m, 5H), 7.47 (d, J = 7.0 
Hz, 2H), 7.43–7.30 (m, 3H), 7.28 (dd, J = 9.0 Hz, 1.5 Hz, 2H), 7.23 (d, J = 8.5 Hz, 2H), 7.06 (dd, J = 8.5 Hz, 
5.5Hz, 1H), 6.89 (d, J = 7.5 Hz, 2H), 5.88 (br, 1H), 5.40 (br, 1H); 
13CNMR (125 MHz, CDCl3, 23 ºC): δ 163.3, 
153.8, 153.3, 149.0, 144.4, 143.1, 142.0, 138.3, 138.2, 136.5, 135.1, 130.6, 130.3, 129.0, 128.5, 127.6, 126.9, 
126.8, 126.0, 125.5, 125.4, 124.8, 124.4, 122.4, 121.6; HRMS-FIA (m/z): [M + H]
+ calcd for C31H23N5O5PdS, 
684.0528; found, 684.0537. Anal: calcd for C31H23N5O5PdS: C, 54.43; H, 3.39; N, 10.24; found: C, 54.43; H, 
3.67; N, 9.95. 
 
Aryl palladium complex 4g 
K2CO3
MeOH:benzene 
(1:1)
70 %
NP d
N
N
S
NO2 O O
4g
NP d
N
N
OAc
S
NO2 O O
1
OH (HO)2B
OH
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To acetato palladium complex 1 (400 mg, 0.642 mmol, 1.00 equiv) in MeOH (12.8 mL) and benzene (12.8 
mL) at 23 ºC is added 4-hydroxyphenylboronic acid (97 mg, 0.706 mmol, 1.10 equiv) and K2CO3 (133 mg, 
0.963 mmol, 1.50 equiv). The reaction mixture is stirred at 23 ºC for 15 h, and the solvent is removed in 
vacuo. To the solid residue is added CHCl3 (5 mL) and water (5 mL). The phases are separated and the 
aqueous phase is extracted with CHCl3 (3 × 5 mL). The combined organic phases are washed with brine (5 
mL) and dried (Na2SO4). The filtrate is concentrated in vacuo and the residue is purified by chromatography 
on silica gel eluting with hexane/EtOAc 2:3 (v/v) to afford 295 mg of the title compound as a yellow solid 
(70%yield). 
TLC (hexane/EtOAc, 1:1 v/v): RF = 0.17; m.p.: 174 ºC (decomp.); 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 8.99 
(d, J = 6.5 Hz, 2H), 8.27 (dd, J = 5.0 Hz, 1.5 Hz, 1H), 7.94 (dd, J = 7.5 Hz, 1.5Hz, 1H), 7.79–7.68 (m, 5H), 
7.47 (d, J = 9.0 Hz, 2H), 7.40–7.27 (m, 5H), 7.04 (dd, J = 7.5 Hz, 5.5 Hz, 1H), 6.60 (d, J = 8.0 Hz, 2H), 6.38 
(d, J = 8.0 Hz, 2H), 4.40 (s, 1H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 154.1, 153.4, 152.7, 149.2, 147.8, 
147.4, 144.6, 143.4, 142.2, 137.9, 136.4, 134.8, 130.5, 130.1, 128.5, 127.5, 127.0, 126.8, 125.1, 124.7, 124.3, 
122.4, 121.4, 114.5; HRMS-FIA (m/z): [M + H]
+ calcd for C30H22N4O5PdS, 657.0419; found, 657.0433. Anal: 
calcd for C30H22N4O5PdS: C, 54.84; H, 3.38; N, 8.53; found: C, 54.56; H, 3.53; N, 8.26. 
 
Aryl palladium complex 4h 
K2CO3
MeOH:benzene 
(1:1)
79 %
NP d
N
N
S
NO2 O O
4h
NP d
N
N
OAc
S
NO2 O O
1
OMe (HO)2B
OMe
 
To acetato palladium complex 1 (400 mg, 0.642 mmol, 1.00 equiv) in MeOH (12.8 mL) and benzene (12.8 
mL) at 23 ºC is added 4-methoxyphenylboronic acid (107 mg, 0.706 mmol, 1.10 equiv) and K2CO3 (133 mg, 
0.963 mmol, 1.50 equiv). The reaction mixture is stirred at 23 ºC for 3.0 h, and the solvent is removed in 
vacuo. To the solid residue is added CHCl3 (5 mL) and water (5 mL). The phases are separated and the 
aqueous phase is extracted with CHCl3 (3 × 5 mL). The combined organic phases are washed with brine (5 
mL) and dried (Na2SO4). The filtrate is concentrated in vacuo and the residue is purified by chromatography 
on silica gel eluting with hexane/EtOAc 1:1 (v/v) to afford 340 mg of the title compound as a yellow solid 
(79% yield). 
TLC (hexane/EtOAc 1:1, v/v): RF = 0.29; m.p.: 154 ºC (decomp.); 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 8.99 
(d, J = 5.5 Hz, 2H), 8.27 (d, J = 5.5 Hz, 1H), 7.94 (dd, J = 8.0 Hz, 1.5 Hz, 1H), 7.80–7.68 (m, 5H), 7.47 (d, J 
= 6.0 Hz, 2H), 7.38 (d, J = 8.5 Hz, 1H), 7.35–7.28 (m, 4H), 7.04 (dd, J = 8.0 Hz, 5.5 Hz, 1H), 6.64 (d, J = 8.0 
Hz, 2H), 6.44 (d, J = 8.0 Hz, 2H), 3.65 (s, 3H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 156.9, 154.1, 153.5, Supporting Information    S15 
 
149.3, 147.8, 144.6, 143.5, 142.3, 137.9, 137.9, 136.5, 134.7, 130.5, 130.1, 128.6, 127.5, 127.0, 126.8, 125.1, 
124.7, 124.3, 122.4, 121.5, 113.1, 55.1; HRMS-FIA (m/z): [M + H]
+ calcd for C31H24N4O5PdS, 671.0575; 
found, 671.0598.  Anal: calcd for C31H24N4O5PdS: C, 55.49; H, 3.61; N, 8.35; found: C, 55.71; H, 3.37; N, 
8.12. 
 
Aryl palladium complex 4i 
K2CO3
MeOH:benzene 
(1:1)
65 %
NP d
N
N
S
NO2 O O
4i
NP d
N
N
OAc
S
NO2 O O
1
Br (HO)2B
Br
 
To acetato palladium complex 1 (400 mg, 0.642 mmol, 1.00 equiv) in MeOH (12.8 mL) and benzene (12.8 
mL) at 23 ºC is added 4-bromophenylboronic acid (142 mg, 0.706 mmol, 1.10 equiv) and K2CO3 (133 mg, 
0.963 mmol, 1.50 equiv). The reaction mixture is stirred at 23 ºC for 3.5 h, and the solvent is removed in 
vacuo. To the solid residue is added CHCl3 (5 mL) and water (5 mL). The phases are separated and the 
aqueous phase is extracted with CHCl3 (3 × 5 mL). The combined organic phases are washed with brine (5 
mL) and dried (Na2SO4). The filtrate is concentrated in vacuo and the residue is purified by chromatography 
on silica gel eluting with hexane/EtOAc 3:2 (v/v) to afford 300 mg of the title compound as a yellow solid 
(65% yield). 
TLC (hexane/EtOAc, 1:1 v/v): RF = 0.79; m.p.: 201 ºC (decomp.); 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 8.96 
(d, J = 5.0 Hz, 2H), 8.22 (d, J = 5.0 Hz, 1H), 7.96 (d, J = 8.0 Hz, 1H), 7.82–7.68 (m, 5H), 7.47 (d, J = 9.0 Hz, 
2H) 7.42–7.26 (m, 5H), 7.09 (dd, J = 7.5 Hz, 5.0 Hz, 1H), 6.92 (d, J = 8.0 Hz, 2H), 6.70 (d, J = 8.0 Hz, 2H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 154.0, 153.5, 153.3, 149.1, 147.9, 142.0, 138.2, 138.1, 136.5, 136.3, 
130.6, 130.3, 129.9, 128.5, 127.6, 126.9, 126.8, 125.3, 124.8, 124.4, 122.8, 122.4, 121.7, 118.3; HRMS-FIA 
(m/z): [M + H]
+ calcd for C30H21BrN4O4PdS, 718.9575; found, 718.9578. Anal: calcd for C30H21BrN4O4PdS: 
C, 50.05; H, 2.94; N, 7.78; found: C, 50.03; H, 2.91; N, 7.51. 
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Aryl palladium complex 4k 
K2CO3
MeOH:benzene 
(1:1)
90 %
NP d
N
N
S
NO2 O O
4k
NP d
N
N
OAc
S
NO2 O O
1
(HO)2B
Cl
Cl
 
To acetato palladium complex 1 (400 mg, 0.642 mmol, 1.00 equiv) in MeOH (12.8 mL) and benzene (12.8 
mL) at 23 ºC is added 5-chloro-2-methylphenylboronic acid (120 mg, 0.706 mmol, 1.10 equiv) and K2CO3 
(133 mg, 0.963 mmol, 1.50 equiv). The reaction mixture is stirred at 23 ºC for 10 h, and the solvent is 
removed in vacuo. To the solid residue is added CHCl3 (5 mL) and water (5 mL). The phases are separated 
and the aqueous phase is extracted with CHCl3 (3 × 5 mL). The combined organic phases are washed with 
brine (5 mL) and dried (Na2SO4). The filtrate is concentrated in vacuo and the residue is purified by 
chromatography on silica gel eluting with hexane/EtOAc 3:2 (v/v) to afford 398 mg of the title compound as a 
yellow solid (90% yield, 1:1.3 atropisomeric mixture with respect to the palladium–carbon bond). 
TLC (hexane/EtOAc, 1:1 v/v): RF = 0.37; m.p.: 178 ºC (decomp.); 
1H-NMR, both rotamers (500 MHz, CDCl3, 
23 ºC): δ 8.98 (d, J = 5.5 Hz), 8.91 (d, J = 5.5 Hz), 8.28 (d, J = 5.0 Hz), 7.96–7.90 (m), 7.81–7.66 (m), 7.55–
7.46 (m), 7.40–7.28 (m), 7.08–6.98 (m), 6.81 (d, J = 8.0 Hz), 6.74 (dd, J = 8.0 Hz, 2.0 Hz), 6.62 (d, J = 2.0 
Hz), 6.44 (d, J = 8.0 Hz), 2.99 (s), 1.69 (s); 
13C-NMR, both rotamers (125 MHz, CDCl3, 23 ºC): δ 159.6, 
159.1, 153.6, 153.4, 152.9, 152.8, 149.4, 147.9, 144.7, 144.6, 142.0, 141.8, 140.1, 139.1, 138.2, 138.1, 138.0, 
136.5, 133.4, 132.8, 130.7, 130.6, 130.4, 130.3, 130.2, 129.9, 129.2, 129.0, 128.5, 128.4, 127.8, 127.3, 127.0, 
126.8, 126.7, 125.4, 125.2, 125.0, 124.8, 124.5, 124.3, 123.9, 123.8, 122.5, 122.4, 121.6, 24.5, 24.2; HRMS-
FIA (m/z): [M + H]
+ calcd for C31H23ClN4O4PdS, 689.0236; found, 689.0251. Anal: calcd for 
C31H23ClN4O4PdS: C, 54.00; H, 3.36; N, 8.13; found: C, 53.72; H, 3.10; N, 8.03. 
 
Aryl palladium complex 4l 
K2CO3
MeOH:benzene 
(1:1)
88 %
NP d
N
N
S
NO2 O O
4i
NP d
N
N
OAc
S
NO2 O O
1
CF3 (HO)2B
CF3
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To acetato palladium complex 1 (400 mg, 0.642 mmol, 1.00 equiv) in MeOH (12.8 mL) and benzene (12.8 
mL) at 23 ºC is added 4-(trifluoromethyl)phenylboronic acid (134 mg, 0.706 mmol, 1.10 equiv) and K2CO3 
(133 mg, 0.963 mmol, 1.50 equiv). The reaction mixture is stirred at 23 ºC for 10 h, and the solvent is 
removed in vacuo. To the solid residue is added CHCl3 (5 mL) and water (5 mL). The phases are separated 
and the aqueous phase is extracted with CHCl3 (3 × 5 mL). The combined organic phases are washed with 
brine (5 mL) and dried (Na2SO4). The filtrate is concentrated in vacuo and the residue is purified by 
chromatography on silica gel eluting with hexane/EtOAc 3:2 (v/v) to afford 400 mg of the title compound as a 
yellow solid (88% yield). 
TLC (hexane/EtOAc, 1:1 v/v): RF = 0.43; m.p.: 171 ºC (decomp.); 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 8.97 
(d, J = 5.5 Hz, 2H), 8.18 (dd, J = 4.5 Hz, 1.5 Hz, 1H), 7.97 (dd, J = 7.5 Hz, 1.5 Hz, 1H), 7.82–7.70 (m, 5H), 
7.48 (d, J = 7.0 Hz, 2H), 7.42–7.26 (m, 5H), 7.09 (dd, J = 8.0 Hz, 5.0 Hz, 1H), 7.02 (d, J = 8.0 Hz, 2H), 6.99 
(d, J = 8.0 Hz, 2H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 161.3, 153.9, 153.3, 149.0, 147.9, 144.4, 141.9, 
138.3, 138.2, 136.5, 135.0, 130.6, 129.5 (q, J = 238 Hz), 127.6, 126.9, 126.8, 126.2 (q, J = 23 Hz), 125.4, 
124.8, 124.4, 123.9, 123.2, 122.4, 121.7; 
19F-NMR (375 MHz, CDCl3, 23 ºC): δ –62.5; HRMS-FIA (m/z): [M 
+ H]
+ calcd for C31H21F3N4O4PdS, 709.0343; found, 709.0321. Anal: calcd for C31H21F3N4O4PdS: C, 52.51; H, 
2.99; N, 7.90; found: C, 52.29; H, 2.98; N, 7.78. 
 
Aryl palladium complex 4m 
K2CO3
MeOH:benzene 
(1:1)
76 %
NP d
N
N
S
NO2 O O
4m
NP d
N
N
OAc
S
NO2 O O
1
N
Boc
B
O
O
N
Boc
 
To acetato palladium complex 1 (400 mg, 0.642 mmol, 1.00 equiv) in MeOH (12.8 mL) and benzene (12.8 
mL) at 23 ºC is added 1-Boc-indole-5-boronic acid pinacol ester (242 mg, 0.706 mmol, 1.10 equiv) and 
K2CO3 (133 mg, 0.963 mmol, 1.50 equiv). The reaction mixture is stirred at 23 ºC for 6.0 h. After filtered 
through a plug of celite, the solvent is removed in vacuo. To the solid residue is added CHCl3 (5 mL) and 
water (5 mL). The phases are separated and the aqueous phase is extracted with CHCl3 (3 × 5 mL). The 
combined organic phases are washed with brine (5 mL) and dried (Na2SO4). The filtrate is concentrated in 
vacuo and the residue is purified by chromatography on silica gel eluting with hexane/EtOAc 1:1 (v/v) to 
afford 380 mg of the title compound as a yellow solid (76% yield). Supporting Information    S18 
 
TLC (hexane/EtOAc, 3:7 v/v): RF = 0.26; m.p.: 175 ºC (decomp.); 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 9.01 
(d, J = 5.0 Hz, 2H), 8.28 (dd, J = 5.0 Hz, 1.5 Hz, 1H), 7.91 (dd, J = 8.5 Hz, 1.5Hz, 1H), 7.80–7.70 (m, 5H), 
7.61 (br, 1H) 7.47 (d, J = 9.0 Hz, 2H), 7.38 (d, J = 9.0 Hz, 2H), 7.33–7.28 (m, 4H), 7.00–6.95 (m, 2H), 6.81 
(d, J = 8.0 Hz, 1H), 6.25 (d, J = 2.0 Hz, 1H), 1.60 (s, 9H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 153.9, 
153.4, 150.1, 149.3, 147.8,147.7, 144.6, 142.3, 137.9, 136.5, 130.5, 130.1, 130.0, 128.6, 127.5, 127.0, 126.8, 
126.0, 125.1, 125.0, 124.7, 124.6, 124.4, 122.4, 121.5, 119.9, 113.8, 106.8, 83.4, 28.4; HRMS-FIA (m/z): [M 
+ Na]
+ calcd for C37H31N5O6PdS, 802.0922; found, 802.0895. Anal: calcd for C37H31N5O6PdS: C, 56.96; H, 
4.01; N, 8.98; found: C, 56.84; H, 3.94; N, 8.65. 
 
Fluorobenzene 5a 
NP d
N
N
S
NO2 O O
4a
N
N
F
Cl
BF4
BF4
MeCN, 50 °C
F
5a
81 %
 
To 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (2), (4.3 mg, 0.012 mmol, 
1.2 equiv) in acetonitrile-d-3 (0.3 mL) at 50 ºC is added aryl palladium complex 4a (6.4 mg, 0.010 mmol, 1.0 
equiv) as a solid in 10 portions over 10 min. The reaction mixture is stirred at 50 ºC for 20min. The reaction 
mixture is cooled to 23 ºC, and the yield is determined by comparing integration of the 
19F-NMR (375 MHz, 
acetonitrile-d-3, 23 ºC) resonance of fluorobenzene (–115.3 ppm) and that of 3-nitrofluorobenzene (–112.0 
ppm, 2.00 μL, 0.0188 mmol). (81% yield). The 
19F-NMR chemical shift of the product corresponds to that of 
authentic sample purchased from Aldrich.  
1-tert-Butyl-4-fluorobenzene 5b 
NP d
N
N
S
NO2 O O
4b
N
N
F
Cl
BF4
BF4
MeCN, 50 °C
F
5b
79 %
tBu
 
To 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (2) (4.3 mg, 0.012 mmol, 
1.2 equiv) in acetonitrile-d-3 (0.3 mL) at 50 ºC is added aryl palladium complex 4b (7.0 mg, 0.010 mmol, 1.0 Supporting Information    S19 
 
equiv) as a solid in 10 portions over 10 min. The reaction mixture is stirred at 50 ºC for 20 min. The reaction 
mixture is cooled to 23 ºC, and the yield is determined by comparing integration of the 
19F-NMR (375 MHz, 
acetonitrile-d-3, 23 ºC) resonance of 1-tert-butyl-4-fluorobenzene (–120.7 ppm) and that of 3-
nitrofluorobenzene (–112.0 ppm, 2.00 μL, 0.0188 mmol). (79% yield). The 
19F-NMR chemical shift of the 
product corresponds to that of reported data.
9  
4-Fluorobiphenyl 5c 
NP d
N
N
S
NO2 O O
4c
N
N
F
Cl
BF4
BF4
MeCN, 50 °C
F
5c
72 %
Ph
Ph
 
To 1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (2) (85.0 mg, 0.240 
mmol, 1.20 equiv) in acetonitrile (6.0 mL) at 50 ºC is added aryl palladium complex 4c (143 mg, 0.200 mmol, 
1.00 equiv) as a solid in 10 portions over 10 min. The reaction mixture is stirred at 50 ºC for 20 min. After 
cooled to 23 ºC, to the reaction mixture is added pyridine (8.1 μL, 0.10 mmol, 1.0 equiv), and filtered through 
a plug of celite. The filtrate is concentrated in vacuo and the residue is purified by chromatography on silica 
gel eluting with hexane/EtOAc 99:1 (v/v) to afford 24.8 mg of the title compound as a white solid (72% yield). 
TLC (hexane/EtOAc, 19:1 v/v): RF = 0.60; 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 7.60–7.54 (m, 4H), 7.47 (dd, 
J = 7.5 Hz, 7.0 Hz, 2H), 7.36 (t, J = 7.5 Hz, 1H), 7.14 (dd, J = 8.0 Hz, 7.5 Hz, 2H); 
13C-NMR (125 MHz, 
CDCl3, 23 ºC): δ 162.7 (d, J = 244 Hz), 140.5, 137.6, 129.0, 128.9 (d, J = 8.5 Hz), 127.5, 127.3, 115.8 (d, J = 
21 Hz); 
19F-NMR (375 MHz, CDCl3, 23 ºC): δ –116.2. These spectroscopic data correspond to those of 
authentic sample purchased from Alfa Aesar.  
                                                      
 
9 Laali, K. K., Okazaki, T. Bunge, S. D. N-(Trifluoromethylsulfonyl)aryloxytrifluoromethylsulfoximines 
[ArO-SO(CF3)=NTf] and N-aryltriflimides Ar-N(Tf)2 by thermal and photolytic dediazoniation of 
[ArN2][BF4] in [BMIM][Tf2N] ionic liquid: exploiting the ambident nucleophilic character of a 
"nonnucleophilic" anion. J. Org. Chem. 72, 6758-6762 (2007). Supporting Information    S20 
 
4-Fluorobenzylalcohol 5d 
NP d
N
N
S
NO2 O O
4d
N
N
F
Cl
BF4
BF4
MeCN, 50 °C
F
5d
70 %
OH
OH
 
To 1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (2) (42.5 mg, 0.120 
mmol, 1.20 equiv) in acetonitrile (3.0 mL) at 50 ºC is added aryl palladium complex 4d (67.1 mg, 0.100 
mmol, 1.00 equiv) as a solid in 10 portions over 10 min. The reaction mixture is stirred at 50 ºC for 20 min. 
After cooled to 23 ºC, to the reaction mixture is added pyridine (8.1 μL, 0.10 mmol, 1.0 equiv). After 
concentrated in vacuo, the residue is purified by preparative TLC eluting with pentane/Et2O 7:3 (v/v) to afford 
8.8 mg of the title compound as colorless oil (70% yield). 
TLC (hexane/EtOAc 7:3 v/v): RF = 0.61; 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 7.29–7.25 (m, 2H), 7.05–7.00 
(dd, J = 8.0 Hz, 7.5 Hz, 2H), 4.55 (s, 2H), 3.10 (br, 1H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 162.5 (d, J = 
243 Hz), 136.8, 129.0 (d, J = 8.3 Hz), 115.6 (d, J = 21 Hz), 64.5; 
19F-NMR (375 MHz, CDCl3, 23 ºC): δ –
115.4. These spectroscopic data correspond to those of authentic sample purchased from Alfa Aesar.  
4-Fluorobenzaldehyde 5e 
NP d
N
N
S
NO2 O O
4e
N
N
F
Cl
BF4
BF4
MeCN, 50 °C
F
5e
61 %
O
O
 
To 1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (2) (42.5 mg, 0.120 
mmol, 1.20 equiv) in acetonitrile (3.0 mL) at 50 ºC is added aryl palladium complex 4e (66.9 mg, 0.100 mmol, 
1.00 equiv) as a solid in 10 portions over 10 min. The reaction mixture is stirred at 50 ºC for 20 min. After 
cooled to 23 ºC, to the reaction mixture is added pyridine (8.1 μL, 0.10 mmol, 1.0 equiv). After concentrated 
in vacuo, the residue is purified by preparative TLC eluting with pentane/Et2O 7:3 (v/v) to afford 8.8 mg of 
the title compound as colorless oil (61% yield). 
TLC (hexane/EtOAc, 7:3 v/v): RF = 0.77; 
1H-NMR (500 MHz, CDCl3 23 ºC): δ 9.95 (s, 1H), 7.92–7.88 (m, Supporting Information    S21 
 
2H), 7.22–7.18 (dd, J = 8.0 Hz, 7.5 Hz, 2H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 190.7, 166.7 (d, J = 255 
Hz), 133.2, 132.5 (d, J = 9.9 Hz), 116.6 (d, J = 22 Hz); 
19F-NMR (375 MHz, CDCl3, 23 ºC): δ –102.9. These 
spectroscopic data correspond to those of authentic sample purchased from Aldrich.  
4-Fluorobenzmide 5f 
NP d
N
N
S
NO2 O O
4f
N
N
F
Cl
BF4
BF4
MeCN, 50 °C
F
5f
74 %
O
O
H2N
H2N
 
To 1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (2) (42.5 mg, 0.120 
mmol, 1.20 equiv) in acetonitrile (3.0 mL) at 50 ºC is added aryl palladium complex 4f (68.4 mg, 0.100 mmol, 
1.00 equiv) as a solid in 10 portions over 10 min. The reaction mixture is stirred at 50 ºC for 20 min. After 
cooled to 23 ºC, to the reaction mixture is added pyridine (8.1 μL, 0.10 mmol, 1.0 equiv). After concentrated 
in vacuo, the residue is purified by preparative TLC eluting with EtOAc to afford 10.3 mg of the title 
compound as colorless oil (74% yield). 
TLC (EtOAc): RF = 0.40; 
1H-NMR (500 MHz, DMSO-d-6, 23 ºC): δ 8.02 (br, 1H), 7.95 (dd, J = 9.0 Hz, 
6.0Hz, 2H), 7.42 (br, 1H), 7.26 (dd, J = 7.5 Hz, 7.0 Hz, 2H); 
13C-NMR (125 MHz, DMSO-d-6, 23 ºC): δ 
167.6, 164.6 (d, J = 247 Hz), 131.4, 130.8 (d, J = 14 Hz), 115.8 (d, J = 21 Hz); 
19F-NMR (375 MHz, DMSO-
d-6, 23 ºC): δ –110.0. These spectroscopic data correspond to those of authentic sample purchased from Alfa 
Aesar.  
4-Fluorophenol 5g 
NP d
N
N
S
NO2 O O
4g
N
N
F
Cl
BF4
BF4
MeCN, 50 °C
F
5g
31 %
OH
HO
 
To 1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (2) (85.0 mg, 0.240 
mmol, 1.20 equiv) in acetone (6.0 mL) at 50 ºC is added aryl palladium complex 4g (131 mg, 0.200 mmol, Supporting Information    S22 
 
1.00 equiv) as a solid in 10 portions over 10 min. The reaction mixture is stirred at 50 ºC for 20 min. After 
cooled to 23 ºC, to the reaction mixture is added pyridine (16 μL, 0.20 mmol, 1.0 equiv). After concentrated 
in vacuo, the residue is purified by preparative TLC eluting with Hexane/EtOAc 7:3 (v/v) to afford 6.9 mg of 
the title compound as a white solid (31% yield). 
TLC (hexane/EtOAc, 7:3 v/v): RF = 0.58; 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 6.95–6.95 (dd, J = 8.0 Hz, 
7.5 Hz, 2H), 6.80–6.76 (m, 2H), 5.41 (s, 1H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 157.6 (d, J = 237 Hz), 
151.5, 116.5 (d, J = 8.0 Hz), 116.3 (d, J = 21 Hz); 
19F-NMR (375 MHz, CDCl3, 23 ºC): δ –124.3. These 
spectroscopic data correspond to those of authentic sample purchased from Aldrich. 
4-Fluoroanisole 5h 
NP d
N
N
S
NO2 O O
4h
N
N
F
Cl
BF4
BF4
MeCN, 50 °C
F
5h
46 %
OMe
MeO
 
To 1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (2) (85.0 mg, 0.240 
mmol, 1.20 equiv) in acetone (6.0 mL) at 50 ºC is added aryl palladium complex 4h (134 mg, 0.200 mmol, 
1.00 equiv) as a solid in 10 portions over 10 min. The reaction mixture is stirred at 50 ºC for 20 min. After 
cooled to 23 ºC, to the reaction mixture is added pyridine (16 μL, 0.20 mmol, 1.0 equiv). After concentrated 
in vacuo, the residue is purified by preparative TLC eluting with pentane/Et2O 9:1 (v/v) to afford 11.6 mg of 
the title compound as colorless oil (46% yield). 
TLC (hexane/EtOAc, 9:1 v/v): RF = 0.55; 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 7.01–6.95 (m, 2H), 6.87–
6.81 (m, 2H), 3.79 (s, 3H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 157.4 (d, J = 247 Hz), 155.9, 116.0 (d, J = 
23 Hz), 115.0 (d, J = 7.7 Hz), 56.0; 
19F-NMR (375 MHz, CDCl3, 23 ºC): δ –124.8. These spectroscopic data 
correspond to those of authentic sample purchased from Alfa Aesar. Supporting Information    S23 
 
1-Bromo-4-fluorobenzene 5i 
NP d
N
N
S
NO2 O O
4i
N
N
F
Cl
BF4
BF4
MeCN, 50 °C
F
5i
73 %
Br
Br
 
To 1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (2) (42.5 mg, 0.120 
mmol, 1.20 equiv) in acetonitrile (3.0 mL) at 50 ºC is added aryl palladium complex 4i (72.0 mg, 0.100 mmol, 
1.00 equiv) as a solid in 10 portions over 10 min. The reaction mixture is stirred at 50 ºC for 20 min. After 
cooled to 23 ºC, to the reaction mixture is added pyridine (8.1 μL, 0.10 mmol, 1.0 equiv). After concentrated 
in vacuo, the residue is purified by preparative TLC eluting with pentane/Et2O 19:1 (v/v) to afford 12.8 mg of 
the title compound as colorless oil (73% yield). 
TLC (hexane/EtOAc, 19:1 v/v): RF = 0.70; 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 7.47–7.42 (m, 2H), 6.98–
6.92 (m, 2H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 162.1 (d, J = 245 Hz), 133.2, (d, J = 8.5 Hz), 117.5 (d, J 
= 23 Hz), 116.8; 
19F-NMR (375 MHz, CDCl3, 23 ºC): δ –115.7. These spectroscopic data correspond to those 
of authentic sample purchased from Alfa Aesar.  
4-Chloro-2-fluorotoluene 5k 
NP d
N
N
S
NO2 O O
4k
N
N
F
Cl
BF4
BF4
MeCN, 50 °C
F
5k
82 %
Cl
Cl
 
To 1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (2) (42.5 mg, 0.120 
mmol, 1.20 equiv) in acetonitrile (3.0 mL) at 50 ºC is added aryl palladium complex 4k (68.9 mg, 0.100 
mmol, 1.00 equiv) as a solid in 10 portions over 10 min. The reaction mixture is stirred at 50 ºC for 20 min. 
After cooled to 23 ºC, to the reaction mixture is added pyridine (8.1 μL, 0.10 mmol, 1.0 equiv). After 
concentrated in vacuo, the residue is purified by preparative TLC eluting with pentane/Et2O 9:1 (v/v) to afford 
11.9 mg of the title compound as colorless oil (82% yield). 
TLC (hexane/EtOAc, 9:1 v/v): RF = 0.72; 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 7.13–7.08 (dd, J = 7.5 Hz, 
7.0 Hz, 2H), 7.05–7.01 (m, 2H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 161.3 (d, J = 246 Hz), 132.3, 132.2 (d, Supporting Information    S24 
 
J = 5.9 Hz), 124.3, 123.6 (d, J = 17 Hz), 116.0 (d, J = 26 Hz), 14.4; 
19F-NMR (375 MHz, CDCl3, 23 ºC): δ –
115.1; These spectroscopic data correspond to those of authentic sample purchased from Alfa Aesar.  
4-Fluorobenzotrifluoride 5l 
NP d
N
N
S
NO2 O O
4l
N
N
F
Cl
BF4
BF4
MeCN, 50 °C
F
5l
54 %
CF3
F3C
 
To 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (2) (4.3 mg, 0.012 mmol, 
1.2 equiv) in acetonitrile-d-3 (0.3 mL) at 50 ºC is added aryl palladium complex 4l (6.4 mg, 0.010 mmol, 1.0 
equiv) as a solid in 10 portions over 10 min. The reaction mixture is stirred at 50 ºC for 20 min. The reaction 
mixture is cooled to 23 ºC, and the yield is determined by comparing integration of the 
19F-NMR (375 MHz, 
acetonitrile-d-3, 23 ºC) resonance of 4-fluorobenzotrifluoride (–109.4 ppm) and that of 3-nitrofluorobenzene 
(–112.0 ppm, 2.00 μL, 0.0188mmol). (54% yield). The 
19F-NMR chemical shift of the product corresponds to 
that of authentic sample purchased from Alfa Aesar.  
N-Boc-5-fluoroindole 5m 
NP d
N
N
S
NO2 O O
4m
N
N
F
Cl
BF4
BF4
acetone, 50 °C
F
5m
60 %
N
Boc
N
Boc
 
To 1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (2) (42.5 mg, 0.120 
mmol, 1.20 equiv) in acetone (3.0 mL) at 50 ºC is added aryl palladium complex 4m (78.0 mg, 0.100 mmol, 
1.00 equiv) as a solid in 10 portions over 10 min. The reaction mixture is stirred at 50 ºC for 20 min. After 
cooled to 23 ºC, to the reaction mixture is added pyridine (8.1 μL, 0.10 mmol, 1.0 equiv). After concentrated 
in vacuo, the residue is purified by preparative TLC eluting with hexane/EtOAc 7:3 (v/v) to afford 14.1 mg of 
the title compound as colorless oil (60% yield). 
TLC (hexane/EtOAc 7:3 v/v): RF = 0.753; 
1H-NMR (500 MHz, CDCl3, 23 ºC): δ 8.08 (br, 1H), 7.62 (d, J = Supporting Information    S25 
 
4.0 Hz, 1H), 7.20 (dd, J = 6.5 Hz, J = 2.0 Hz, 1H), 7.03 (ddd, J = 7.0 Hz, 6.5 Hz, 2.0 Hz, 1H), 6.52 (d, J = 4.0 
Hz, 1H), 1.68 (s, 9H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 159.5 (d, J = 238 Hz), 149.7, 131.8, 131.6 (d, J 
= 10 Hz), 127.7, 116.3 (d, J = 9.1 Hz), 112.2 (d, J = 24 Hz), 107.2, 106.5 (d, J = 24 Hz), 84.1, 28.4; 
19F-NMR 
(375 MHz, CDCl3, 23 ºC): δ –121.7. These spectroscopic data correspond to those of authentic sample 
independently synthesized from 5-fluoroinodole and Boc2O.  
Bispyridine palladium tetrafluoroborate salt 8 
AgBF4, 
pyridine
MeCN
93 %
NP d
N
N
N
S
NO2 O O
8
NP d
N
N
Cl
S
NO2 O O
7
BF4
-
 
To chloro palladium complex 7 (59.9 mg, 0.100 mmol, 1.00 equiv) in acetonitrile (1.0mL) at 23 ºC is added 
AgBF4 (38.8 mg, 0.200 mmol, 2.00 equiv). The suspension is stirred at 23 ºC for 1.0 hour and to the 
suspension is added pyridine (8.1 μL, 0.10 mmol, 1.0 equiv). The suspension is filtered through a plug of 
celite and the filtrate is concentrated in vacuo to afford 67.9 mg of the title compound as an orange solid (67.9 
mg, 93% yield). 
1H-NMR (500 MHz, acetone-d-6, 23 ºC): δ 9.29 (d, J = 5.5 Hz, 2H), 8.99 (d, J = 5.5 Hz, 2H), 8.51 (dd, J = 
5.5 Hz, 1.5 Hz, 1H), 8.44 (dd, J = 7.5 Hz, 1.0 Hz, 1H), 8.15–8.08 (m, 3H), 8.01 (dd, J = 8.0 Hz, 7.5 Hz, 1H), 
7.89 (t, J = 7.5 Hz, 1H), 7.80–7.70 (m, 4H), 7.66 (d, J = 9.0 Hz, 2H), 7.59–7.52 (m, 4H), 7.48 (dd, J = 8.0 Hz, 
5.5 Hz, 1H); 
13C-NMR (125 MHz, CDCl3, 23 ºC): δ 152.6, 152.4, 152.3, 152.2, 152.9, 152.8, 148.7, 147.2, 
141.4, 140.8, 140.7, 140.6, 140.5, 140.3, 140.2, 137.7, 136.5, 130.8, 130.6, 130.3, 129.2, 128.8, 127.9, 127.8, 
127.4, 127.2, 126.9, 126.8, 126.7, 126.5, 125.2, 124.9, 123.9, 123.8, 123.1, 122.9, 118.4.  The complex 
13C 
spectrum is presumably due to pyridine exchange with the NMR solvent acetone.  
19F-NMR (375 MHz, 
acetone-d-6, 23 ºC): δ –151.5; HRMS-FIA (m/z): [M – C5H5N + C2H3N – BF4]
+ calcd for C31H24N4O5PdS, 
604.0265; found, 604.0228. Supporting Information    S26 
 
X-ray Crystallographic Analysis 
Firgure S1.: acetato palladium complex 1 (CCDC 67599) 
 
The x-ray structure of acetato palladium complex 1 with hydrogens and with the atom labeling scheme 
employed. The nonhydrogen atoms are depicted with 50% probability ellipsoids. 
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Table S2.: Crystal data and structure refinement for acetato palladium complex 1. 
____________________________________________________________________________________ 
Identification code   CCDC 675999 = [Pd(C5H5N)(C2H3O2)(C19H12N3O4S)] 
Formula   C26 H20 N4 O6 Pd S 
Formula weight   622.92 
Temperature   193(2) K 
Wavelength   0.71073 Å 
Crystal system   Triclinic 
Space group   P 1 ¯ (No. 2) 
Unit cell dimensions  a = 9.1803(2) Å  α= 67.735(1)° 
  b = 11.3199(2) Å  β= 87.215(1)° 
  c = 12.8456(2) Å  γ = 75.798(1)° 
Volume 1196.16(4)  Å3 
Z 2 
Density (calculated)  1.730 Mg/m3 
Absorption coefficient  0.916 mm-1 
F(000) 628 
Crystal size  0.175 x 0.150 x 0.025 mm3 
Theta range for data collection  1.72 to 27.50° 
Index ranges  -11<=h<=11, -14<=k<=14, -16<=l<=16 
Reflections collected  17370 
Independent reflections  5486 [R(int) = 0.0586] 
Completeness to theta = 27.50°  100.0 %  
Absorption correction  Numerical 
Max. and min. transmission  0.9775 and 0.8562 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters  5486 / 0 / 344 
Goodness-of-fit on F2 1.030 
Final R indices [I>2sigma(I)]  R1 = 0.0376, wR2 = 0.0859 
R indices (all data)  R1 = 0.0518, wR2 = 0.0935 
Largest diff. peak and hole  0.525 and -0.543 e.Å-3 
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Figure S2.: aryl palladium complex 4a (CCDC 676000) 
 
 
The x-ray structure of aryl palladium complex 4a with hydrogens and with the atom labeling scheme 
employed. The nonhydrogen atoms are depicted with 50% probability ellipsoids. Supporting Information    S29 
 
Table S3.: Crystal data and structure refinement for aryl palladium complex 4a. 
____________________________________________________________________________________ 
Identification code   CCDC 676000 = [Pd(C5H5N)(C6H5)(C19H12N3O4S)] 
Empirical formula   C30 H22 N4 O4 Pd S 
Formula weight   640.98 
Temperature   193(2) K 
Wavelength   0.71073 Å 
Crystal system   Orthorhombic 
Space group   P212121 (No. 19) 
Unit cell dimensions  a = 9.5439(2) Å  α= 90° 
  b = 13.8697(2) Å  β= 90° 
  c = 19.5047(3) Å  γ = 90° 
Volume 2581.86(8)  Å3 
Z 4 
Density (calculated)  1.649 Mg/m3 
Absorption coefficient  0.846 mm-1 
F(000) 1296 
Crystal size  0.125 x 0.075 x 0.050 mm3 
Theta range for data collection  1.80 to 27.50° 
Index ranges  -12<=h<=12, -18<=k<=18, -25<=l<=25 
Reflections collected  67549 
Independent reflections  5932 [R(int) = 0.1052] 
Completeness to theta = 27.50°  100.0 %  
Absorption correction  Semi-empirical from equivalents 
Max. and min. transmission  0.9589 and 0.9016 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters  5932 / 0 / 361 
Goodness-of-fit on F2 1.050 
Final R indices [I>2sigma(I)]  R1 = 0.0329, wR2 = 0.0657 
R indices (all data)  R1 = 0.0427, wR2 = 0.0698 
Absolute structure parameter  -0.03(2) 
Largest diff. peak and hole  0.488 and -0.576 e.Å-3 
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Spectroscopic Data 
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